CHRS
Coherus Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.42
+3.65%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.61x
- Price / sales
- 4.31x
- Price / cash flow
- -0.90x
Enterprise value
- Enterprise value
- $151.8M
- EV / sales
- 2.98x
- EV / EBITDA
- -1.02x
- EV / EBIT
- -0.97x
- Market cap
- $219.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026